Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Birtle

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 15, 2000
Anthracyclines and cardiotoxicityA J Birtle
Histopathology|July 2, 2004
The androgen receptor revisited in urothelial carcinomaA J Birtle, A Freeman, P Munson
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 19, 2019
A Case Series of Cabazitaxel Re-Challenge Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer who Have Previously Received Docetaxel and Cabazitaxel ChemotherapyC L Barker, C Slater, A J Birtle
Parasitology|April 1, 1984
Triphasic locomotor response of a plant-parasitic nematode to avermectin: inhibition by the GABA antagonists bicuculline and picrotoxinD J Wright, A J Birtle, I T Roberts
The British Journal of Clinical Practice|September 1, 1995
Deep vein thrombosisM R Tyrrell, A J Birtle, P R Taylor
British Journal of Cancer|September 24, 2004
Epirubicin carboplatin and 5-fluorouracil (ECarboF) chemotherapy in metastatic hormone refractory prostate cancerA J Birtle, J C Newby, S J Harland
Postgraduate Medical Journal|November 13, 2003
Prostate cancer management: (1) an update on localised diseaseS R J Bott, A J Birtle, C J Taylor, et al.
Postgraduate Medical Journal|December 5, 2003
Prostate cancer management: 2. An update on locally advanced and metastatic diseaseS R J Bott, A J Birtle, C J Taylor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2005
Can bleomycin toxicity in the treatment of testis cancer be batch related?A J Birtle, R A Huddart, A H Horwich, et al.
BJU International|August 22, 2003
Neuroendocrine differentiation in prostate cancer: is it detectable and treatable?A J Birtle, A Freeman, H A Payne, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 15, 2000
Anthracyclines and cardiotoxicityA J Birtle
Histopathology|July 2, 2004
The androgen receptor revisited in urothelial carcinomaA J Birtle, A Freeman, P Munson
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 19, 2019
A Case Series of Cabazitaxel Re-Challenge Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer who Have Previously Received Docetaxel and Cabazitaxel ChemotherapyC L Barker, C Slater, A J Birtle
Parasitology|April 1, 1984
Triphasic locomotor response of a plant-parasitic nematode to avermectin: inhibition by the GABA antagonists bicuculline and picrotoxinD J Wright, A J Birtle, I T Roberts
The British Journal of Clinical Practice|September 1, 1995
Deep vein thrombosisM R Tyrrell, A J Birtle, P R Taylor
British Journal of Cancer|September 24, 2004
Epirubicin carboplatin and 5-fluorouracil (ECarboF) chemotherapy in metastatic hormone refractory prostate cancerA J Birtle, J C Newby, S J Harland
Postgraduate Medical Journal|November 13, 2003
Prostate cancer management: (1) an update on localised diseaseS R J Bott, A J Birtle, C J Taylor, et al.
Postgraduate Medical Journal|December 5, 2003
Prostate cancer management: 2. An update on locally advanced and metastatic diseaseS R J Bott, A J Birtle, C J Taylor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2005
Can bleomycin toxicity in the treatment of testis cancer be batch related?A J Birtle, R A Huddart, A H Horwich, et al.
BJU International|August 22, 2003
Neuroendocrine differentiation in prostate cancer: is it detectable and treatable?A J Birtle, A Freeman, H A Payne, et al.
Pageof 2